| Year |
Citation |
Score |
| 2021 |
Burke RM, Shih S, Hsiung CA, Yen C, Jiang B, Parashar UD, Tate JE, Wu FT, Huang YC. Impact of rotavirus vaccination on rotavirus hospitalizations in Taiwanese children. Vaccine. PMID 34785101 DOI: 10.1016/j.vaccine.2021.10.064 |
0.355 |
|
| 2021 |
Myat TW, Thu HM, Tate JE, Burnett E, Cates JE, Parashar UD, Kyaw YM, Khaing TEE, Moh KM, Win NN, Khine WK, Kham MMZ, Kyaw T, Khine YY, Oo KK, et al. Rotavirus infection among children under five years of age hospitalized with acute gastroenteritis in Myanmar during 2018-2020 - Multicentre surveillance before rotavirus vaccine introduction. Vaccine. PMID 34702620 DOI: 10.1016/j.vaccine.2021.10.014 |
0.372 |
|
| 2021 |
Haber M, Tate JE, Lopman BA, Qi W, Ainslie KEC, Parashar UD. Comparing statistical methods for detecting and estimating waning efficacy of rotavirus vaccines in developing countries. Human Vaccines & Immunotherapeutics. 1-4. PMID 34613877 DOI: 10.1080/21645515.2021.1968738 |
0.321 |
|
| 2021 |
Glass RI, Tate JE, Jiang B, Parashar U. The Rotavirus Vaccine Story: From Discovery to the Eventual Control of Rotavirus Disease. The Journal of Infectious Diseases. 224: S331-S342. PMID 34590142 DOI: 10.1093/infdis/jiaa598 |
0.389 |
|
| 2021 |
Hagan LM, McCormick DW, Lee C, Sleweon S, Nicolae L, Dixon T, Banta R, Ogle I, Young C, Dusseau C, Salmonson S, Ogden C, Godwin E, Ballom T, Ross T, ... ... Tate JE, et al. Outbreak of SARS-CoV-2 B.1.617.2 (Delta) Variant Infections Among Incarcerated Persons in a Federal Prison - Texas, July-August 2021. Mmwr. Morbidity and Mortality Weekly Report. 70: 1349-1354. PMID 34555009 DOI: 10.15585/mmwr.mm7038e3 |
0.319 |
|
| 2021 |
Mpabalwani EM, Bvulani B, Simwaka J, Chitambala P, Matapo B, Tate J, Parashar U, Mwenda J. Age distribution and mortality associated with intussusception in children under two years of age in nine sentinel surveillance hospitals in Zambia, 2007-2018. The Pan African Medical Journal. 39: 6. PMID 34548898 DOI: 10.11604/pamj.supp.2021.39.1.26671 |
0.31 |
|
| 2021 |
Toussaint TW, Wandaogo A, Yaméogo W IC, Ouédraogo I, Ouédraogo SMF, Zampou O, Béré B, Aliabadi N, Leshem E, Nikièma M, Ouattara M, Mwenda JM, Bonkoungou I, Bandré E, Parashar UD, ... Tate JE, et al. Acute intestinal intussusception among children under five years of age admitted in an Ouagadougou hospital, Burkina Faso, 2008-2013: epidemiological, clinical and therapeutic aspects. The Pan African Medical Journal. 39: 5. PMID 34548897 DOI: 10.11604/pamj.supp.2021.39.1.25270 |
0.308 |
|
| 2021 |
Cates J, Tate JE, Parashar U. Rotavirus vaccines: progress and new developments. Expert Opinion On Biological Therapy. PMID 34482790 DOI: 10.1080/14712598.2021.1977279 |
0.381 |
|
| 2021 |
Desormeaux AM, Burnett E, Joseph G, Lucien MAB, Aliabadi N, Pierre M, Dély P, Pierre K, Fitter D, Leshem E, Tate JE, Bowen MD, Esona M, Gautier J, Siné F, et al. Impact of Monovalent Rotavirus Vaccine on Rotavirus Hospitalizations among Children Younger Than 5 Years of Age in the Ouest and Artibonite Departments, Haiti, 2013 to 2019. The American Journal of Tropical Medicine and Hygiene. PMID 34398813 DOI: 10.4269/ajtmh.21-0414 |
0.37 |
|
| 2021 |
Burke RM, Tate JE, Parashar UD. Global Experience with Rotavirus Vaccines. The Journal of Infectious Diseases. PMID 34374426 DOI: 10.1093/infdis/jiab399 |
0.368 |
|
| 2021 |
Kempe A, O'Leary ST, Cortese MM, Crane LA, Cataldi JR, Brtnikova M, Beaty BL, Hurley LP, Gorman C, Tate JE, St Pierre JL, Lindley MC. WHY AREN'T WE ACHIEVING HIGH VACCINATION RATES FOR ROTAVIRUS VACCINE IN THE U.S.? Academic Pediatrics. PMID 34252608 DOI: 10.1016/j.acap.2021.07.003 |
0.319 |
|
| 2021 |
Burnett E, Juin S, Esona MD, Desormeaux AM, Aliabadi N, Pierre M, Andre-Alboth J, Leshem E, Etheart MD, Patel R, Dely P, Fitter D, Jean-Denis G, Kalou M, Katz MA, ... ... Tate JE, et al. Effectiveness of monovalent rotavirus vaccine against hospitalizations due to all rotavirus and equine-like G3P[8] genotypes in Haiti 2014-2019. Vaccine. PMID 34187708 DOI: 10.1016/j.vaccine.2021.06.055 |
0.35 |
|
| 2021 |
Burnett E, Parashar UD, Tate JE. Rotavirus Infection, Illness, and Vaccine Performance in Malnourished Children: A Review of the Literature. The Pediatric Infectious Disease Journal. PMID 34117200 DOI: 10.1097/INF.0000000000003206 |
0.339 |
|
| 2021 |
Mwenda JM, Hallowell BD, Parashar U, Shaba K, Biey JN, Weldegebriel GG, Paluku GK, Ntsama B, N'diaye A, Bello IM, Bwaka AM, Zawaira FR, Mihigo R, Tate JE. Impact of rotavirus vaccine introduction on rotavirus hospitalizations among children under 5 years of age - World Health Organization African Region, 2008-2018. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 34089588 DOI: 10.1093/cid/ciab520 |
0.35 |
|
| 2021 |
Newall AT, Leong RN, Reyes JF, Curns AT, Rudd J, Tate J, Macartney K, Parashar U. Rotavirus vaccination likely to be cost saving to society in the United States. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 34038527 DOI: 10.1093/cid/ciab442 |
0.304 |
|
| 2021 |
Salmon DA, Lambert PH, Nohynek HM, Gee J, Parashar UD, Tate JE, Wilder-Smith A, Hartigan-Go KY, Smith PG, Zuber PLF. Novel vaccine safety issues and areas that would benefit from further research. Bmj Global Health. 6. PMID 34011502 DOI: 10.1136/bmjgh-2020-003814 |
0.344 |
|
| 2021 |
Debellut F, Clark A, Pecenka C, Tate J, Baral R, Sanderson C, Parashar U, Atherly D. Evaluating the potential economic and health impact of rotavirus vaccination in 63 middle-income countries not eligible for Gavi funding: a modelling study. The Lancet. Global Health. PMID 33891885 DOI: 10.1016/S2214-109X(21)00167-4 |
0.339 |
|
| 2020 |
Haber P, Tate J, Marquez PL, Moro PL, Parashar U. Safety profile of rotavirus vaccines among individuals aged ≥8 months of age, United States, vaccine adverse event reporting system (VAERS), 2006-2019. Vaccine. PMID 33267969 DOI: 10.1016/j.vaccine.2020.11.026 |
0.308 |
|
| 2020 |
Reddy SN, Nair NP, Tate JE, Thiyagarajan V, Giri S, Praharaj I, Mohan VR, Babji S, Gupte MD, Arora R, Bidari S, Senthamizh S, Mekala S, Goru KB, Reddy B, et al. Intussusception after Rotavirus Vaccine Introduction in India. The New England Journal of Medicine. 383: 1932-1940. PMID 33176083 DOI: 10.1056/NEJMoa2002276 |
0.322 |
|
| 2020 |
Burnett E, Rahajamanana VL, Raboba JL, Weldegebriel G, Vuo Masembe Y, Mwenda JM, Parashar UD, Tate JE, Robinson AL. Diarrhea hospitalization costs among children <5 years old in Madagascar. Vaccine. PMID 33051040 DOI: 10.1016/j.vaccine.2020.09.082 |
0.352 |
|
| 2020 |
Burnett E, Parashar UD, Tate JE. Real-world effectiveness of rotavirus vaccines, 2006-19: a literature review and meta-analysis. The Lancet. Global Health. 8: e1195-e1202. PMID 32827481 DOI: 10.1016/S2214-109X(20)30262-X |
0.343 |
|
| 2020 |
Mwanga MJ, Owor BE, Ochieng JB, Ngama MH, Ogwel B, Onyango C, Juma J, Njeru R, Gicheru E, Otieno GP, Khagayi S, Agoti CN, Bigogo GM, Omore R, Addo OY, ... ... Tate JE, et al. Rotavirus group A genotype circulation patterns across Kenya before and after nationwide vaccine introduction, 2010-2018. Bmc Infectious Diseases. 20: 504. PMID 32660437 DOI: 10.1186/s12879-020-05230-0 |
0.324 |
|
| 2020 |
Hallowell BD, Tate J, Parashar U. An overview of rotavirus vaccination programs in developing countries. Expert Review of Vaccines. 1-9. PMID 32543239 DOI: 10.1080/14760584.2020.1775079 |
0.339 |
|
| 2020 |
Burke RM, Groom HC, Naleway AL, Katz EM, Salas B, Mattison CP, Donald J, Tsaknaridis L, Biggs C, Bowen MD, Tate JE, Parashar UD, Schmidt M, Hall AJ. Rotavirus Vaccine is Effective Against Rotavirus Gastroenteritis Resulting in Outpatient Care: Results from the MAAGE Study. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 32322882 DOI: 10.1093/cid/ciaa466 |
0.355 |
|
| 2020 |
Burnett E, Parashar UD, Tate JE. Global impact of rotavirus vaccination on diarrhea hospitalizations and deaths among children <5 years old: 2006-2019. The Journal of Infectious Diseases. PMID 32095831 DOI: 10.1093/infdis/jiaa081 |
0.326 |
|
| 2020 |
Baker JM, Tate JE, Leon J, Haber MJ, Pitzer VE, Lopman BA. Post-vaccination serum anti-rotavirus immunoglobulin A as a correlate of protection against rotavirus gastroenteritis across settings. The Journal of Infectious Diseases. PMID 32060525 DOI: 10.1093/Infdis/Jiaa068 |
0.33 |
|
| 2020 |
Parashar UD, Tate JE. The control of diarrhea, the case of a rotavirus vaccine. Salud Publica De Mexico. 62: 1-5. PMID 31869556 DOI: 10.21149/9943 |
0.311 |
|
| 2019 |
Baker JM, Tate JE, Leon J, Haber MJ, Lopman BA. Antirotavirus IgA seroconversion rates in children who receive concomitant oral poliovirus vaccine: A secondary, pooled analysis of Phase II and III trial data from 33 countries. Plos Medicine. 16: e1003005. PMID 31887139 DOI: 10.1371/Journal.Pmed.1003005 |
0.374 |
|
| 2019 |
Burnett E, Kabir F, Van Trang N, Rayamajhi A, Satter SM, Liu J, Yousafzai MT, Anh DD, Basnet AT, Flora MS, Houpt E, Qazi SH, Canh TM, Rayamajhi AK, Saha BK, ... ... Tate JE, et al. Infectious etiologies of intussusception among children <2 years old in 4 Asian countries. The Journal of Infectious Diseases. PMID 31754717 DOI: 10.1093/Infdis/Jiz621 |
0.322 |
|
| 2019 |
Debellut F, Clark A, Pecenka C, Tate J, Baral R, Sanderson C, Parashar U, Kallen L, Atherly D. Re-evaluating the potential impact and cost-effectiveness of rotavirus vaccination in 73 Gavi countries: a modelling study. The Lancet. Global Health. 7: e1664-e1674. PMID 31708147 DOI: 10.1016/S2214-109X(19)30439-5 |
0.345 |
|
| 2019 |
Clark A, Tate J, Parashar U, Jit M, Hasso-Agopsowicz M, Henschke N, Lopman B, Van Zandvoort K, Pecenka C, Fine P, Sanderson C. Mortality reduction benefits and intussusception risks of rotavirus vaccination in 135 low-income and middle-income countries: a modelling analysis of current and alternative schedules. The Lancet. Global Health. 7: e1541-e1552. PMID 31607466 DOI: 10.1016/S2214-109X(19)30412-7 |
0.331 |
|
| 2019 |
Payne DC, Englund JA, Weinberg GA, Halasa NB, Boom JA, Staat MA, Selvarangan R, Azimi PH, Klein EJ, Szilagyi PG, Chappell J, Sahni LC, McNeal M, Harrison CJ, Moffatt ME, ... ... Tate JE, et al. Association of Rotavirus Vaccination With Inpatient and Emergency Department Visits Among Children Seeking Care for Acute Gastroenteritis, 2010-2016. Jama Network Open. 2: e1912242. PMID 31560386 DOI: 10.1001/jamanetworkopen.2019.12242 |
0.35 |
|
| 2019 |
Otieno GP, Bottomley C, Khagayi S, Adetifa I, Ngama M, Omore R, Ogwel B, Owor BE, Bigogo G, Ochieng JB, Onyango C, Juma J, Mwenda J, Tabu C, Tate JE, et al. Impact of the introduction of rotavirus vaccine on hospital admissions for diarrhoea among children in Kenya: A controlled interrupted time series analysis. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 31544211 DOI: 10.1093/cid/ciz912 |
0.354 |
|
| 2019 |
Mokomane M, Esona MD, Bowen MD, Tate JE, Steenhoff AP, Lechiile K, Gaseitsiwe S, Seheri LM, Magagula NB, Weldegebriel G, Pernica JM, Mwenda JM, Kasvosve I, Parashar UD, Goldfarb DM. Diversity of Rotavirus Strains Circulating in Botswana before and after introduction of the Monovalent Rotavirus Vaccine. Vaccine. PMID 31530468 DOI: 10.1016/j.vaccine.2019.09.022 |
0.363 |
|
| 2019 |
Pindyck T, Tate JE, Bonkoungou IJO, Armah G, Mujuru HA, Rugambwa C, Mwenda JM, Parashar U. Timeliness of rotavirus vaccination at sentinel sites in four early-adopter African countries. Vaccine. PMID 31455587 DOI: 10.1016/j.vaccine.2019.08.008 |
0.308 |
|
| 2019 |
Jere KC, Bar-Zeev N, Chande A, Bennett A, Pollock L, Sanchez-Lopez PF, Nakagomi O, Tate JE, Parashar UD, Heyderman RS, French N, Iturriza-Gomara M, Cunliffe NA. Vaccine Effectiveness against DS-1-Like Rotavirus Strains in Infants with Acute Gastroenteritis, Malawi, 2013-2015. Emerging Infectious Diseases. 25: 1734-1737. PMID 31441761 DOI: 10.3201/eid2509.190258 |
0.343 |
|
| 2019 |
Khagayi S, Omore R, Otieno GP, Ogwel B, Ochieng JB, Juma J, Apondi E, Bigogo G, Onyango C, Ngama M, Njeru R, Owor BE, Mwanga MJ, Addo Y, Tabu C, ... ... Tate JE, et al. Effectiveness of monovalent rotavirus vaccine against hospitalization with acute rotavirus gastroenteritis in Kenyan children. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 31326980 DOI: 10.1093/cid/ciz664 |
0.352 |
|
| 2019 |
Burke RM, Tate JE, Han GS, Quenelle R, Gautam R, Wadford DA, Bowen MD, Parashar UD. Rotavirus Vaccination Coverage During a Rotavirus Outbreak Resulting in a Fatality at a Subacute Care Facility. Journal of the Pediatric Infectious Diseases Society. PMID 31318031 DOI: 10.1093/jpids/piz015 |
0.347 |
|
| 2019 |
Burke RM, Tate JE, Kirkwood CD, Steele AD, Parashar UD. Current and new rotavirus vaccines. Current Opinion in Infectious Diseases. PMID 31305493 DOI: 10.1097/QCO.0000000000000572 |
0.338 |
|
| 2019 |
Hallowell BD, Parashar UD, Curns A, DeGroote NP, Tate JE. Trends in the Laboratory Detection of Rotavirus Before and After Implementation of Routine Rotavirus Vaccination - United States, 2000-2018. Mmwr. Morbidity and Mortality Weekly Report. 68: 539-543. PMID 31220058 DOI: 10.15585/mmwr.mm6824a2 |
0.362 |
|
| 2019 |
Aliabadi N, Antoni S, Mwenda JM, Weldegebriel G, Biey JNM, Cheikh D, Fahmy K, Teleb N, Ashmony HA, Ahmed H, Daniels DS, Videbaek D, Wasley A, Singh S, de Oliveira LH, ... ... Tate JE, et al. Global impact of rotavirus vaccine introduction on rotavirus hospitalisations among children under 5 years of age, 2008-16: findings from the Global Rotavirus Surveillance Network. The Lancet. Global Health. 7: e893-e903. PMID 31200889 DOI: 10.1016/S2214-109X(19)30207-4 |
0.36 |
|
| 2019 |
Burke RM, Tate JE, Dahl RM, Aliabadi N, Parashar UD. Does Rotavirus Vaccination Affect Longer-Term Intussusception Risk in US Infants? Journal of the Pediatric Infectious Diseases Society. PMID 31197368 DOI: 10.1093/jpids/piz035 |
0.333 |
|
| 2019 |
Clark A, van Zandvoort K, Flasche S, Sanderson C, Bines J, Tate J, Parashar U, Jit M. Efficacy of live oral rotavirus vaccines by duration of follow-up: a meta-regression of randomised controlled trials. The Lancet. Infectious Diseases. PMID 31178289 DOI: 10.1016/S1473-3099(19)30126-4 |
0.34 |
|
| 2019 |
Groome MJ, Tate JE, Arnold M, Chitnis M, Cox S, de Vos C, Kirsten M, le Grange SM, Loveland J, Machaea S, Maharaj A, Andrews N, Madhi SA, Parashar UD. Evaluation of intussusception after oral monovalent rotavirus vaccination in South Africa. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 31125061 DOI: 10.1093/cid/ciz431 |
0.336 |
|
| 2019 |
Haber M, Lopman BA, Tate JE, Shi M, Parashar UD. Effect of propensity of seeking medical care on the bias of the estimated effectiveness of rotavirus vaccines from studies using a test-negative case-control design. Vaccine. PMID 31036459 DOI: 10.1016/J.Vaccine.2019.04.065 |
0.324 |
|
| 2019 |
Nair NP, Reddy N S, Giri S, Mohan VR, Parashar U, Tate J, Shah MP, Arora R, Gupte M, Mehendale SM, Kang G. Rotavirus vaccine impact assessment surveillance in India: protocol and methods. Bmj Open. 9: e024840. PMID 31028037 DOI: 10.1136/bmjopen-2018-024840 |
0.369 |
|
| 2019 |
Clark AD, Hasso-Agopsowicz M, Kraus MW, Stockdale LK, Sanderson CFB, Parashar UD, Tate JE. Update on the global epidemiology of intussusception: a systematic review of incidence rates, age distributions and case-fatality ratios among children aged <5 years, before the introduction of rotavirus vaccination. International Journal of Epidemiology. PMID 30879038 DOI: 10.1093/ije/dyz028 |
0.34 |
|
| 2019 |
Ahmed MC, Heukelbach J, Weddih A, Filali-Maltouf A, Sidatt M, Makhalla K, Dahdi S, Cheikh Ahmed AC, El-Mami MV, Tate JE, Parashar UD, Benhafid M. Reduction of hospitalizations with diarrhea among children aged 0-5 years in Nouakchott, Mauritania, following the introduction of rotavirus vaccine. Vaccine. 37: 1407-1411. PMID 30765173 DOI: 10.1016/j.vaccine.2019.01.078 |
0.345 |
|
| 2019 |
Aliabadi N, Wikswo ME, Tate JE, Cortese MM, Szilagyi PG, Staat MA, Weinberg GA, Halasa NB, Boom JA, Selvarangan R, Englund JA, Azimi PH, Klein EJ, Moffatt ME, Harrison CJ, et al. Factors Associated With Rotavirus Vaccine Coverage. Pediatrics. PMID 30655333 DOI: 10.1542/peds.2018-1824 |
0.35 |
|
| 2019 |
Lusvan ME, Debellut F, Clark A, Demberelsuren S, Otgonbayar D, Batjargal T, Purevsuren S, Groman D, Tate J, Pecenka C. Projected impact, cost-effectiveness, and budget implications of rotavirus vaccination in Mongolia. Vaccine. PMID 30639458 DOI: 10.1016/j.vaccine.2018.12.056 |
0.347 |
|
| 2019 |
Omore R, Khagayi S, Ogwel B, Onkoba R, Ochieng JB, Juma J, Munga S, Tabu C, Kibet S, Nuorti JP, Odhiambo F, Mwenda JM, Breiman RF, Parashar UD, Tate JE. Rates of hospitalization and death for all-cause and rotavirus acute gastroenteritis before rotavirus vaccine introduction in Kenya, 2010-2013. Bmc Infectious Diseases. 19: 47. PMID 30634922 DOI: 10.1186/s12879-018-3615-6 |
0.367 |
|
| 2019 |
Hallowell BD, Parashar UD, Curns A, DeGroote N, Tate J. 93. Trends in the Laboratory Detection of Rotavirus Before and After Implementation of Routine Rotavirus Vaccination: the United States, 2000–2018 Open Forum Infectious Diseases. 6: S8-S8. DOI: 10.1093/ofid/ofz359.017 |
0.363 |
|
| 2018 |
Mujuru HA, Burnett E, Nathoo KJ, Ticklay I, Gonah NA, Mukaratirwa A, Berejena C, Manangazira P, Rupfutse M, Weldegebriel GG, Mwenda JM, Yen C, Parashar UD, Tate JE. Monovalent rotavirus vaccine effectiveness against rotavirus hospitalizations among children in Zimbabwe. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 30590488 DOI: 10.1093/cid/ciy1096 |
0.371 |
|
| 2018 |
Tate JE, Parashar UD. Approaches to Monitoring Intussusception Following Rotavirus Vaccination. Expert Opinion On Drug Safety. PMID 30570424 DOI: 10.1080/14740338.2019.1561857 |
0.303 |
|
| 2018 |
Chavers TP, de Oliveira LH, Parashar UD, Tate JE. Post-Licensure experience with rotavirus vaccination in Latin America and the Caribbean: a systematic review and meta-analysis. Expert Review of Vaccines. PMID 30365904 DOI: 10.1080/14760584.2018.1541409 |
0.384 |
|
| 2018 |
Tate JE, Mwenda JM, Parashar UD. Intussusception after Rotavirus Vaccination in Africa. The New England Journal of Medicine. 379: 1288-1289. PMID 30257154 DOI: 10.1056/NEJMc1807645#SA2 |
0.351 |
|
| 2018 |
Lopez AL, Daag JV, Esparagoza J, Bonifacio J, Fox K, Nyambat B, Parashar UD, Ducusin MJ, Tate JE. Effectiveness of monovalent rotavirus vaccine in the Philippines. Scientific Reports. 8: 14291. PMID 30250267 DOI: 10.1038/s41598-018-32595-9 |
0.317 |
|
| 2018 |
Cohen AL, Aliabadi N, Serhan F, Tate JE, Zuber P, Parashar UD. Using surveillance and economic data to make informed decisions about rotavirus vaccine introduction. Vaccine. PMID 30131194 DOI: 10.1016/j.vaccine.2018.05.052 |
0.356 |
|
| 2018 |
Bar-Zeev N, King C, Phiri T, Beard J, Mvula H, Crampin AC, Heinsbroek E, Lewycka S, Tate JE, Parashar UD, Costello A, Mwansambo C, Heyderman RS, French N, Cunliffe NA, et al. Impact of monovalent rotavirus vaccine on diarrhoea-associated post-neonatal infant mortality in rural communities in Malawi: a population-based birth cohort study. The Lancet. Global Health. 6: e1036-e1044. PMID 30103981 DOI: 10.1016/S2214-109X(18)30314-0 |
0.347 |
|
| 2018 |
Baker JM, Tate JE, Steiner CA, Haber MJ, Parashar UD, Lopman BA. Longer-term direct and indirect effects of infant rotavirus vaccination across all ages in the US; 2000 - 2013: analysis of a large hospital discharge dataset. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 30020438 DOI: 10.1093/Cid/Ciy580 |
0.334 |
|
| 2018 |
Mwenda JM, Parashar UD, Cohen AL, Tate JE. Impact of rotavirus vaccines in Sub-Saharan African countries. Vaccine. PMID 29914848 DOI: 10.1016/j.vaccine.2018.06.026 |
0.357 |
|
| 2018 |
Pindyck T, Tate JE, Parashar UD. A decade of experience with rotavirus vaccination in the United States - vaccine uptake, effectiveness, and impact. Expert Review of Vaccines. PMID 29909693 DOI: 10.1080/14760584.2018.1489724 |
0.38 |
|
| 2018 |
Simwaka JC, Mpabalwani EM, Seheri M, Peenze I, Monze M, Matapo B, Parashar UD, Mufunda J, Mphahlele JM, Tate JE, Mwenda JM. Diversity of rotavirus strains circulating in children under five years of age who presented with acute gastroenteritis before and after rotavirus vaccine introduction, University Teaching Hospital, Lusaka, Zambia, 2008-2015. Vaccine. PMID 29907481 DOI: 10.1016/j.vaccine.2018.03.035 |
0.349 |
|
| 2018 |
Bennett A, Pollock L, Jere KC, Pitzer VE, Parashar U, Tate JE, Heyderman RS, Mwansambo C, French N, Nakagomi O, Iturriza-Gomara M, Everett D, Cunliffe NA, Bar-Zeev N. Direct and possible indirect effects of vaccination on rotavirus hospitalisations among children in Malawi four years after programmatic introduction. Vaccine. PMID 29887320 DOI: 10.1016/j.vaccine.2018.04.030 |
0.375 |
|
| 2018 |
Mpabalwani EM, Simwaka JC, Mwenda JM, Matapo B, Parashar UD, Tate JE. Sustained impact of rotavirus vaccine on rotavirus hospitalisations in Lusaka, Zambia, 2009-2016. Vaccine. PMID 29793891 DOI: 10.1016/j.vaccine.2018.02.077 |
0.358 |
|
| 2018 |
Abou-Nader A, Sauer M, Steele AD, Tate JE, Atherly D, Parashar UD, Santosham M, Nelson EAS. Global Rotavirus Vaccine Introductions and Coverage: 2006 - 2016. Human Vaccines & Immunotherapeutics. 1-40. PMID 29787334 DOI: 10.1080/21645515.2018.1470725 |
0.36 |
|
| 2018 |
Sibomana H, Rugambwa C, Mwenda JM, Sayinzoga F, Iraguha G, Uwimana J, Parashar UD, Tate JE. Impact of routine rotavirus vaccination on all-cause and rotavirus hospitalizations during the first four years following vaccine introduction in Rwanda. Vaccine. PMID 29754701 DOI: 10.1016/j.vaccine.2018.01.072 |
0.368 |
|
| 2018 |
Enweronu-Laryea CC, Armah G, Sagoe KW, Ansong D, Addo-Yobo E, Diamenu SK, Mwenda JM, Parashar UD, Tate JE. Sustained impact of rotavirus vaccine introduction on rotavirus gastroenteritis hospitalizations in children <5 years of age, Ghana, 2009-2016. Vaccine. PMID 29752020 DOI: 10.1016/j.vaccine.2018.02.058 |
0.365 |
|
| 2018 |
Lopez AL, Raguindin PF, Esparagoza J, Fox K, Batmunkh N, Bonifacio J, Parashar UD, Tate JE, Ducusin MJ. Impact of rotavirus vaccine on diarrheal hospitalization and outpatient consultations in the Philippines: First evidence from a middle-income Asian country. Vaccine. PMID 29729994 DOI: 10.1016/j.vaccine.2018.04.058 |
0.344 |
|
| 2018 |
Burke RM, Tate JE, Barin N, Bock C, Bowen MD, Chang D, Gautam R, Han G, Holguin J, Huynh T, Pan CY, Quenelle R, Sallenave C, Torres C, Wadford D, et al. Three Rotavirus Outbreaks in the Postvaccine Era - California, 2017. Mmwr. Morbidity and Mortality Weekly Report. 67: 470-472. PMID 29698381 DOI: 10.15585/mmwr.mm6716a3 |
0.38 |
|
| 2018 |
Mukaratirwa A, Berejena C, Nziramasanga P, Ticklay I, Gonah A, Nathoo K, Manangazira P, Mangwanya D, Marembo J, Mwenda JM, Weldegebriel G, Seheri M, Tate JE, Yen C, Parashar U, et al. Distribution of rotavirus genotypes associated with acute diarrhoea in Zimbabwean children less than five years old before and after rotavirus vaccine introduction. Vaccine. PMID 29628149 DOI: 10.1016/j.vaccine.2018.03.069 |
0.345 |
|
| 2018 |
Sanneh B, Papa Sey A, Shah M, Tate J, Sonko M, Jagne S, Jarju M, Sowe D, Taal M, Cohen A, Parashar U, Mwenda JM. Impact of pentavalent rotavirus vaccine against severe rotavirus diarrhoea in The Gambia. Vaccine. PMID 29544688 DOI: 10.1016/j.vaccine.2018.02.091 |
0.362 |
|
| 2018 |
Burnett E, Tate JE, Kirkwood CD, Nelson EAS, Santosham M, Steele AD, Parashar UD. Estimated impact of rotavirus vaccine on hospitalizations and deaths from rotavirus diarrhea among children <5 in Asia. Expert Review of Vaccines. PMID 29463143 DOI: 10.1080/14760584.2018.1443008 |
0.377 |
|
| 2018 |
Liu N, Yen C, Huang T, Cui P, Tate JE, Jiang B, Parashar UD, Duan ZJ. Incidence and epidemiology of intussusception among children under 2 years of age in Chenzhou and Kaifeng, China, 2009-2013. Vaccine. PMID 29439864 DOI: 10.1016/j.vaccine.2018.02.032 |
0.331 |
|
| 2018 |
Tsolenyanu E, Djadou KE, Fiawoo M, Akolly DAE, Mwenda JM, Leshem E, Tate JE, Aliabadi N, Koudema W, Guedenon KM, Godonou M, Dagnra A, Gbadoe AD, Boko A, Landoh D, et al. Evidence of the impact of monovalent rotavirus vaccine on childhood acute gastroenteritis hospitalization in Togo. Vaccine. PMID 29397224 DOI: 10.1016/j.vaccine.2018.01.058 |
0.358 |
|
| 2018 |
Burnett E, Parashar U, Tate J. Rotavirus Vaccines: Effectiveness, Safety, and Future Directions. Paediatric Drugs. PMID 29388076 DOI: 10.1007/s40272-018-0283-3 |
0.389 |
|
| 2018 |
Burke RM, Tate JE, Pringle KD, Patel M, De Oliveira LH, Parashar UD. Effect of Age at Vaccination on Rotavirus Vaccine Effectiveness in Bolivian Infants. The Pediatric Infectious Disease Journal. PMID 29341984 DOI: 10.1097/INF.0000000000001907 |
0.349 |
|
| 2017 |
Bonkoungou IJO, Aliabadi N, Leshem E, Kam M, Nezien D, Drabo MK, Nikiema M, Ouedraogo B, Medah I, Konaté S, Ouédraogo-Traoré R, Sangaré L, Kam L, Yé D, Ouattara M, ... ... Tate JE, et al. Impact and effectiveness of pentavalent rotavirus vaccine in children <5 years of age in Burkina Faso. Vaccine. PMID 29290478 DOI: 10.1016/j.vaccine.2017.12.056 |
0.358 |
|
| 2017 |
Mokomane M, Tate JE, Steenhoff AP, Esona MD, Bowen MD, Lechiile K, Pernica JM, Kasvosve I, Parashar UD, Goldfarb DM. Evaluation of the Influence of Gastrointestinal Co-Infections on Rotavirus Vaccine Effectiveness in Botswana. The Pediatric Infectious Disease Journal. PMID 29189612 DOI: 10.1097/INF.0000000000001828 |
0.347 |
|
| 2017 |
Rayamajhi A, Thapa A, Kumar M, Yen C, Tate JE, Parashar UD, Rayamajhi AK. Preparing for rotavirus vaccine introduction - A retrospective assessment of the epidemiology of intussusception in children below 2 years of age in Nepal. Vaccine. PMID 29169894 DOI: 10.1016/J.Vaccine.2017.11.022 |
0.344 |
|
| 2017 |
Diop A, Thiongane A, Mwenda JM, Aliabadi N, Sonko MA, Diallo A, Ndoye B, Faye PM, Ba ID, Parashar UD, Tate JE, Ndiaye O, Cissé MF, Ba M. Impact of rotavirus vaccine on acute gastroenteritis in children under 5 years in Senegal: Experience of sentinel site of the Albert Royer Children's Hospital in Dakar. Vaccine. PMID 29162319 DOI: 10.1016/j.vaccine.2017.10.061 |
0.329 |
|
| 2017 |
Jere KC, Chaguza C, Bar-Zeev N, Lowe J, Peno C, Kumwenda B, Nakagomi O, Tate JE, Parashar UD, Heyderman RS, French N, Cunliffe NA, Miren IG. Emergence of double- and triple-gene reassortant G1P[8] rotaviruses possessing a DS-1-like backbone post rotavirus vaccine introduction in Malawi. Journal of Virology. PMID 29142125 DOI: 10.1128/JVI.01246-17 |
0.302 |
|
| 2017 |
de Deus N, Chilaúle JJ, Cassocera M, Bambo M, Langa JS, Sitoe E, Chissaque A, Anapakala E, Sambo J, Guimarães EL, Bero DM, João ED, Cossa-Moiane I, Mwenda JM, Weldegebriel GG, ... ... Tate JE, et al. Early impact of rotavirus vaccination in children less than five years of age in Mozambique. Vaccine. PMID 29128381 DOI: 10.1016/j.vaccine.2017.10.060 |
0.371 |
|
| 2017 |
Mwenda JM, Burke RM, Shaba K, Mihigo R, Tevi-Benissan MC, Mumba M, Biey JN, Cheikh D, Poy MSc A, Zawaira FR, Aliabadi N, Tate JE, Hyde T, Cohen AL, Parashar UD. Implementation of Rotavirus Surveillance and Vaccine Introduction - World Health Organization African Region, 2007-2016. Mmwr. Morbidity and Mortality Weekly Report. 66: 1192-1196. PMID 29095805 DOI: 10.15585/mmwr.mm6643a7 |
0.38 |
|
| 2017 |
Shah MP, Mwenda JM, Tate JE, Steele AD, Parashar UD. Estimated reductions in hospitalizations and deaths from childhood diarrhea following implementation of rotavirus vaccination in Africa. Expert Review of Vaccines. PMID 28832219 DOI: 10.1080/14760584.2017.1371595 |
0.357 |
|
| 2017 |
Maphalala G, Phungwayo N, Masona G, Lukhele N, Tsegaye G, Dube N, Sindisiwe D, Khumalo L, Daniel F, Katsande R, Tate JE, Mwenda JM, Weldegebriel G. Early impact of rotavirus vaccine in under 5year old children hospitalized due to diarrhea, Swaziland. Vaccine. PMID 28778615 DOI: 10.1016/j.vaccine.2017.07.072 |
0.37 |
|
| 2017 |
Yen C, Shih SM, Tate JE, Wu FT, Huang YC, Parashar UD, Hsiung CA. Intussusception-related Hospitalizations among Infants before and after Private Market Licensure of Rotavirus Vaccines in Taiwan, 2001-2013. The Pediatric Infectious Disease Journal. PMID 28640005 DOI: 10.1097/INF.0000000000001644 |
0.331 |
|
| 2017 |
Mujuru HA, Yen C, Nathoo KJ, Gonah NA, Ticklay I, Mukaratirwa A, Berejena C, Tapfumanei O, Chindedza K, Rupfutse M, Weldegebriel G, Mwenda JM, Burnett E, Tate JE, Parashar UD, et al. Reduction in Diarrhea- and Rotavirus-related Healthcare Visits among Children <5 Years of Age Following National Rotavirus Vaccine Introduction in Zimbabwe. The Pediatric Infectious Disease Journal. PMID 28640001 DOI: 10.1097/INF.0000000000001648 |
0.365 |
|
| 2017 |
Pecenka C, Parashar U, Tate JE, Khan JAM, Groman D, Chacko S, Shamsuzzaman M, Clark A, Atherly D. Impact and cost-effectiveness of rotavirus vaccination in Bangladesh. Vaccine. PMID 28623028 DOI: 10.1016/j.vaccine.2017.05.087 |
0.347 |
|
| 2017 |
Jonesteller CL, Burnett E, Yen C, Tate JE, Parashar UD. Effectiveness of Rotavirus Vaccination: A systematic review of the first decade of global post-licensure data, 2006-2016. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 28444323 DOI: 10.1093/cid/cix369 |
0.347 |
|
| 2017 |
Verani JR, Baqui AH, Broome CV, Cherian T, Cohen C, Farrar JL, Feikin DR, Groome MJ, Hajjeh RA, Johnson HL, Madhi SA, Mulholland K, O'Brien KL, Parashar UD, Patel MM, ... ... Tate JE, et al. Case-control vaccine effectiveness studies: Preparation, design, and enrollment of cases and controls. Vaccine. PMID 28442231 DOI: 10.1016/J.Vaccine.2017.04.037 |
0.338 |
|
| 2017 |
Verani JR, Baqui AH, Broome CV, Cherian T, Cohen C, Farrar JL, Feikin DR, Groome MJ, Hajjeh RA, Johnson HL, Madhi SA, Mulholland K, O'Brien KL, Parashar UD, Patel MM, ... ... Tate JE, et al. Case-control vaccine effectiveness studies: Data collection, analysis and reporting results. Vaccine. PMID 28442230 DOI: 10.1016/J.Vaccine.2017.04.035 |
0.347 |
|
| 2017 |
Burnett E, Jonesteller CL, Tate JE, Yen C, Parashar UD. Global Impact of Rotavirus Vaccination on Childhood Hospitalizations and Mortality from Diarrhea. The Journal of Infectious Diseases. PMID 28430997 DOI: 10.1093/infdis/jix186 |
0.368 |
|
| 2017 |
Aliabadi N, Haynes A, Tate J, Parashar UD, Curns AT. Trends in the Burden and Seasonality of Rotavirus in the United States, 2000–2016 Open Forum Infectious Diseases. 4: S324-S324. DOI: 10.1093/OFID/OFX163.763 |
0.346 |
|
| 2016 |
Harris VC, Armah G, Fuentes S, Korpela KE, Parashar U, Victor JC, Tate J, de Weerth C, Giaquinto C, Wiersinga WJ, Lewis KD, de Vos WM. The infant gut microbiome correlates significantly with rotavirus vaccine response in rural Ghana. The Journal of Infectious Diseases. PMID 27803175 DOI: 10.1093/Infdis/Jiw518 |
0.324 |
|
| 2016 |
Mpabalwani EM, Mwenda JM, Tate JE, Parashar UD. Review of Naturally Occurring Intussusception in Young Children in the WHO African Region prior to the Era of Rotavirus Vaccine Utilization in the Expanded Programme of Immunization. Journal of Tropical Pediatrics. PMID 27694631 DOI: 10.1093/tropej/fmw069 |
0.329 |
|
| 2016 |
Wu D, Yen C, Yin ZD, Li YX, Liu N, Liu YM, Wang HQ, Cui FQ, Gregory CJ, Tate JE, Parashar UD, Yin DP, Li L. The Public Health Burden of Rotavirus Disease in Children <5 Years of Age and Considerations for Rotavirus Vaccine Introduction in China. The Pediatric Infectious Disease Journal. PMID 27626917 DOI: 10.1097/INF.0000000000001327 |
0.366 |
|
| 2016 |
Yeung KH, Tate JE, Chan CC, Chan MC, Chan PK, Poon KH, Siu SL, Fung GP, Ng KL, Chan IM, Yu PT, Ng CH, Lau YL, Nelson EA. Rotavirus vaccine effectiveness in Hong Kong children. Vaccine. PMID 27595446 DOI: 10.1016/j.vaccine.2016.08.047 |
0.359 |
|
| 2016 |
Tate JE, Yen C, Steiner CA, Cortese MM, Parashar UD. Intussusception Rates Before and After the Introduction of Rotavirus Vaccine. Pediatrics. PMID 27558938 DOI: 10.1542/peds.2016-1082 |
0.335 |
|
| 2016 |
Yen C, Healy K, Tate JE, Parashar UD, Bines J, Neuzil K, Santosham M, Steele AD. Rotavirus vaccination and intussusception - science, surveillance, and safety: a review of evidence and recommendations for future research priorities in low and middle income countries. Human Vaccines & Immunotherapeutics. 0. PMID 27322835 DOI: 10.1080/21645515.2016.1197452 |
0.356 |
|
| 2016 |
Aliabadi N, Tate JE, Parashar UD. Potential safety issues and other factors that may affect the introduction and uptake of rotavirus vaccines. Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases. PMID 27129416 DOI: 10.1016/j.cmi.2016.03.007 |
0.362 |
|
| 2016 |
Shah MP, Tate JE, Steiner CA, Parashar UD. Decline in Emergency Department Visits for Acute Gastroenteritis among Children in 10 US States Following Implementation of Rotavirus Vaccination, 2003-2013. The Pediatric Infectious Disease Journal. PMID 27088585 DOI: 10.1097/INF.0000000000001175 |
0.36 |
|
| 2016 |
Tate JE, Burton AH, Boschi-Pinto C, Parashar UD. Global, Regional, and National Estimates of Rotavirus Mortality in Children <5 Years of Age, 2000-2013. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 62: S96-S105. PMID 27059362 DOI: 10.1093/cid/civ1013 |
0.347 |
|
| 2016 |
Parashar UD, Johnson H, Steele AD, Tate JE. Health Impact of Rotavirus Vaccination in Developing Countries: Progress and Way Forward. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 62: S91-5. PMID 27059361 DOI: 10.1093/cid/civ1015 |
0.358 |
|
| 2016 |
Bar-Zeev N, Jere KC, Bennett A, Pollock L, Tate JE, Nakagomi O, Iturriza-Gomara M, Costello A, Mwansambo C, Parashar UD, Heyderman RS, French N, Cunliffe NA. Population Impact and Effectiveness of Monovalent Rotavirus Vaccination in Urban Malawian Children 3 Years After Vaccine Introduction: Ecological and Case-Control Analyses. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 62: S213-9. PMID 27059359 DOI: 10.1093/cid/civ1183 |
0.368 |
|
| 2016 |
Tate JE, Ngabo F, Donnen P, Gatera M, Uwimana J, Rugambwa C, Mwenda JM, Parashar UD. Effectiveness of Pentavalent Rotavirus Vaccine Under Conditions of Routine Use in Rwanda. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 62: S208-12. PMID 27059358 DOI: 10.1093/cid/civ1016 |
0.341 |
|
| 2016 |
Tsolenyanu E, Mwenda JM, Dagnra A, Leshem E, Godonou M, Nassoury I, Landoh D, Tate JE, Atakouma Y, Parashar UD. Early Evidence of Impact of Monovalent Rotavirus Vaccine in Togo. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 62: S196-9. PMID 27059356 DOI: 10.1093/cid/civ1182 |
0.363 |
|
| 2016 |
Mpabalwani EM, Simwaka CJ, Mwenda JM, Mubanga CP, Monze M, Matapo B, Parashar UD, Tate JE. Impact of Rotavirus Vaccination on Diarrheal Hospitalizations in Children Aged <5 Years in Lusaka, Zambia. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 62: S183-7. PMID 27059354 DOI: 10.1093/cid/civ1027 |
0.338 |
|
| 2016 |
Beres LK, Tate JE, Njobvu L, Chibwe B, Rudd C, Guffey MB, Stringer JS, Parashar UD, Chilengi R. A Preliminary Assessment of Rotavirus Vaccine Effectiveness in Zambia. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 62: S175-82. PMID 27059353 DOI: 10.1093/cid/civ1206 |
0.363 |
|
| 2016 |
Enane LA, Gastañaduy PA, Goldfarb DM, Pernica JM, Mokomane M, Moorad B, Masole L, Tate JE, Parashar UD, Steenhoff AP. Impact of Rotavirus Vaccination on Hospitalizations and Deaths From Childhood Gastroenteritis in Botswana. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 62: S168-74. PMID 27059352 DOI: 10.1093/cid/civ1210 |
0.348 |
|
| 2016 |
Gastañaduy PA, Steenhoff AP, Mokomane M, Esona MD, Bowen MD, Jibril H, Pernica JM, Mazhani L, Smieja M, Tate JE, Parashar UD, Goldfarb DM. Effectiveness of Monovalent Rotavirus Vaccine After Programmatic Implementation in Botswana: A Multisite Prospective Case-Control Study. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 62: S161-7. PMID 27059351 DOI: 10.1093/Cid/Civ1207 |
0.352 |
|
| 2016 |
Leshem E, Givon-Lavi N, Tate JE, Greenberg D, Parashar UD, Dagan R. Real-World Effectiveness of Pentavalent Rotavirus Vaccine Among Bedouin and Jewish Children in Southern Israel. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 62: S155-60. PMID 27059350 DOI: 10.1093/cid/civ1012 |
0.347 |
|
| 2016 |
Pringle KD, Patzi M, Tate JE, Iniguez Rojas V, Patel M, Inchauste Jordan L, Montesano R, Zarate A, De Oliveira L, Parashar U. Sustained Effectiveness of Rotavirus Vaccine Against Very Severe Rotavirus Disease Through the Second Year of Life, Bolivia 2013-2014. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 62: S115-20. PMID 27059344 DOI: 10.1093/cid/civ1026 |
0.354 |
|
| 2016 |
So-Armah KA, Tate JP, Chang CH, Butt AA, Gerschenson M, Gibert CL, Leaf D, Rimland D, Rodriguez-Barradas MC, Budoff MJ, Samet JH, Kuller LH, Deeks SG, Crothers KA, Tracy RP, et al. Do Biomarkers Of Inflammation, Monocyte Activation And Altered Coagulation Explain Excess Mortality Between HIV Infected and Uninfected People? Journal of Acquired Immune Deficiency Syndromes (1999). PMID 26885807 DOI: 10.1097/QAI.0000000000000954 |
0.411 |
|
| 2016 |
Ngabo F, Tate JE, Gatera M, Rugambwa C, Donnen P, Lepage P, Mwenda JM, Binagwaho A, Parashar UD. Effect of pentavalent rotavirus vaccine introduction on hospital admissions for diarrhoea and rotavirus in children in Rwanda: a time-series analysis. The Lancet. Global Health. 4: e129-36. PMID 26823214 DOI: 10.1016/S2214-109X(15)00270-3 |
0.372 |
|
| 2016 |
Burnett E, Yen C, Tate JE, Parashar UD. Rotavirus vaccines: Current global impact and future perspectives Future Virology. 11: 699-708. DOI: 10.2217/fvl-2016-0082 |
0.356 |
|
| 2016 |
Tate J. Rotavirus vaccines - A promise kept International Journal of Infectious Diseases. 45: 38. DOI: 10.1016/J.IJID.2016.02.122 |
0.342 |
|
| 2015 |
Kang G, Tate JE, Parashar UD. Evaluation of rotavirus disease burden and vaccine effectiveness in India. Vaccine. 33: 7143. PMID 26675194 DOI: 10.1016/j.vaccine.2015.08.092 |
0.319 |
|
| 2015 |
Parashar UD, Cortese MM, Payne DC, Lopman B, Yen C, Tate JE. Value of Post-Licensure Data on Benefits and Risks of Vaccination to Inform Vaccine Policy: The Example of Rotavirus Vaccines. American Journal of Preventive Medicine. 49: S377-82. PMID 26590437 DOI: 10.1016/j.amepre.2015.09.005 |
0.349 |
|
| 2015 |
Payne DC, Selvarangan R, Azimi PH, Boom JA, Englund JA, Staat MA, Halasa NB, Weinberg GA, Szilagyi PG, Chappell J, McNeal M, Klein EJ, Sahni LC, Johnston SH, Harrison CJ, ... ... Tate JE, et al. Long-term Consistency in Rotavirus Vaccine Protection: RV5 and RV1 Vaccine Effectiveness in US Children, 2012-2013. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 26449565 DOI: 10.1093/cid/civ872 |
0.362 |
|
| 2015 |
Parashar UD, Cortese MM, Payne DC, Lopman B, Yen C, Tate JE. Value of post-licensure data on benefits and risks of vaccination to inform vaccine policy: The example of rotavirus vaccines. Vaccine. 33: D55-9. PMID 26122581 DOI: 10.1016/j.vaccine.2015.05.094 |
0.35 |
|
| 2015 |
Leshem E, Tate JE, Steiner CA, Curns AT, Lopman BA, Parashar UD. Acute gastroenteritis hospitalizations among US children following implementation of the rotavirus vaccine. Jama. 313: 2282-4. PMID 26057291 DOI: 10.1001/jama.2015.5571 |
0.315 |
|
| 2015 |
Bar-Zeev N, Kapanda L, King C, Beard J, Phiri T, Mvula H, Crampin AC, Mwansambo C, Costello A, Parashar U, Tate JE, Verani JR, Whitney CG, Heyderman RS, Cunliffe NA, et al. Methods and challenges in measuring the impact of national pneumococcal and rotavirus vaccine introduction on morbidity and mortality in Malawi. Vaccine. 33: 2637-45. PMID 25917672 DOI: 10.1016/j.vaccine.2015.04.053 |
0.361 |
|
| 2015 |
Aliabadi N, Tate JE, Haynes AK, Parashar UD. Sustained decrease in laboratory detection of rotavirus after implementation of routine vaccination—United States, 2000-2014. Mmwr. Morbidity and Mortality Weekly Report. 64: 337-42. PMID 25856253 |
0.336 |
|
| 2015 |
Bar-Zeev N, Kapanda L, Tate JE, Jere KC, Iturriza-Gomara M, Nakagomi O, Mwansambo C, Costello A, Parashar UD, Heyderman RS, French N, Cunliffe NA. Effectiveness of a monovalent rotavirus vaccine in infants in Malawi after programmatic roll-out: an observational and case-control study. The Lancet. Infectious Diseases. 15: 422-8. PMID 25638521 DOI: 10.1016/S1473-3099(14)71060-6 |
0.316 |
|
| 2015 |
Sahni LC, Tate JE, Payne DC, Parashar UD, Boom JA. Variation in rotavirus vaccine coverage by provider location and subsequent disease burden. Pediatrics. 135: e432-9. PMID 25583918 DOI: 10.1542/peds.2014-0208 |
0.359 |
|
| 2015 |
Premkumar PS, Parashar UD, Gastanaduy PA, McCracken JP, de Oliveira LH, Payne DC, Patel MM, Tate JE, Lopman BA. Reduced rotavirus vaccine effectiveness among children born during the rotavirus season: a pooled analysis of 5 case-control studies from the Americas. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 60: 1075-8. PMID 25452592 DOI: 10.1093/cid/ciu956 |
0.331 |
|
| 2015 |
Parashar UD, Cortese MM, Payne DC, Lopman B, Yen C, Tate JE. Value of Post-Licensure Data on Benefits and Risks of Vaccination to Inform Vaccine Policy: The Example of Rotavirus Vaccines American Journal of Preventive Medicine. 49: S377-S382. DOI: 10.1016/j.amepre.2015.09.005 |
0.333 |
|
| 2014 |
Tate JE, Arora R, Kang G, Parashar UD. Rotavirus vaccines at the threshold of implementation in India. The National Medical Journal of India. 27: 245-8. PMID 26037421 |
0.361 |
|
| 2014 |
Rao TS, Arora R, Khera A, Tate JE, Parashar U, Kang G. Insights from global data for use of rotavirus vaccines in India. Vaccine. 32: A171-8. PMID 25091672 DOI: 10.1016/j.vaccine.2014.03.029 |
0.353 |
|
| 2014 |
Rha B, Tate JE, Weintraub E, Haber P, Yen C, Patel M, Cortese MM, DeStefano F, Parashar UD. Intussusception following rotavirus vaccination: an updated review of the available evidence. Expert Review of Vaccines. 13: 1339-48. PMID 25066368 DOI: 10.1586/14760584.2014.942223 |
0.351 |
|
| 2014 |
Tate JE, Parashar UD. Rotavirus vaccines in routine use. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 59: 1291-301. PMID 25048849 DOI: 10.1093/cid/ciu564 |
0.382 |
|
| 2014 |
Leshem E, Moritz RE, Curns AT, Zhou F, Tate JE, Lopman BA, Parashar UD. Rotavirus vaccines and health care utilization for diarrhea in the United States (2007-2011). Pediatrics. 134: 15-23. PMID 24913793 DOI: 10.1542/peds.2013-3849 |
0.308 |
|
| 2014 |
Yen C, Tate JE, Hyde TB, Cortese MM, Lopman BA, Jiang B, Glass RI, Parashar UD. Rotavirus vaccines: current status and future considerations. Human Vaccines & Immunotherapeutics. 10: 1436-48. PMID 24755452 DOI: 10.4161/hv.28857 |
0.376 |
|
| 2014 |
Chang WC, Yen C, Wu FT, Huang YC, Lin JS, Huang FC, Yu HT, Chi CL, Lin HY, Tate JE, Parashar UD, Wu HS, Hsiung CA. Effectiveness of 2 rotavirus vaccines against rotavirus disease in Taiwanese infants. The Pediatric Infectious Disease Journal. 33: e81-6. PMID 24569388 DOI: 10.1097/INF.0000000000000105 |
0.342 |
|
| 2014 |
Khagayi S, Tate JE, Onkoba R, Parashar U, Odhiambo F, Burton D, Laserson K, Feikin DR. A sham case-control study of effectiveness of DTP-Hib-hepatitis B vaccine against rotavirus acute gastroenteritis in Kenya. Bmc Infectious Diseases. 14: 77. PMID 24517198 DOI: 10.1186/1471-2334-14-77 |
0.318 |
|
| 2014 |
Rha B, Tate JE, Payne DC, Cortese MM, Lopman BA, Curns AT, Parashar UD. Effectiveness and impact of rotavirus vaccines in the United States - 2006-2012. Expert Review of Vaccines. 13: 365-76. PMID 24392657 DOI: 10.1586/14760584.2014.877846 |
0.373 |
|
| 2014 |
Ngendahayo E, Bonane A, Ntakiyiruta G, Munyanshongore A, Muganga N, Bikoroti J, Mwenda JM, Tate JE, Ngabo F. Preparing for safety monitoring after rotavirus vaccine implementation: a retrospective review of intussusception cases among children at a large teaching hospital in Rwanda, 2009-2012. The Pediatric Infectious Disease Journal. 33: S99-S103. PMID 24343624 DOI: 10.1097/INF.0000000000000093 |
0.344 |
|
| 2014 |
Ngabo F, Gatera M, Karema C, Donnen P, Lepage P, Parashar UD, Tate JE, Mwenda JM, Rugambwa C, Binagwaho A. Can routinely collected national data on childhood morbidity and mortality from diarrhea be used to monitor health impact of rotavirus vaccination in Africa? Examination of pre-vaccine baseline data from Rwanda. The Pediatric Infectious Disease Journal. 33: S89-93. PMID 24343621 DOI: 10.1097/INF.0000000000000054 |
0.365 |
|
| 2014 |
Mwenda JM, Tate JE, Parashar UD, Mihigo R, Agócs M, Serhan F, Nshimirimana D. African rotavirus surveillance network: a brief overview. The Pediatric Infectious Disease Journal. 33: S6-8. PMID 24343616 DOI: 10.1097/INF.0000000000000174 |
0.328 |
|
| 2014 |
Breiman RF, Cosmas L, Audi A, Mwiti W, Njuguna H, Bigogo GM, Olack B, Ochieng JB, Wamola N, Montgomery JM, Williamson J, Parashar UD, Burton DC, Tate JE, Feikin DR. Use of population-based surveillance to determine the incidence of rotavirus gastroenteritis in an urban slum and a rural setting in Kenya. The Pediatric Infectious Disease Journal. 33: S54-61. PMID 24343615 DOI: 10.1097/INF.0000000000000094 |
0.313 |
|
| 2014 |
Mwenda JM, Tate JE, Steele AD, Parashar UD. Preparing for the scale-up of rotavirus vaccine introduction in Africa: establishing surveillance platforms to monitor disease burden and vaccine impact. The Pediatric Infectious Disease Journal. 33: S1-5. PMID 24343605 DOI: 10.1097/INF.0000000000000132 |
0.364 |
|
| 2013 |
Chang WC, Yen C, Chi CL, Wu FT, Huang YC, Lin JS, Huang FC, Tate JE, Wu HS, Hsiung CA. Cost-effectiveness of rotavirus vaccination programs in Taiwan. Vaccine. 31: 5458-65. PMID 24060569 DOI: 10.1016/j.vaccine.2013.08.103 |
0.328 |
|
| 2013 |
Cortese MM, Immergluck LC, Held M, Jain S, Chan T, Grizas AP, Khizer S, Barrett C, Quaye O, Mijatovic-Rustempasic S, Gautam R, Bowen MD, Moore J, Tate JE, Parashar UD, et al. Effectiveness of monovalent and pentavalent rotavirus vaccine. Pediatrics. 132: e25-33. PMID 23776114 DOI: 10.1542/peds.2012-3804 |
0.34 |
|
| 2013 |
Moon SS, Tate JE, Ray P, Dennehy PH, Archary D, Coutsoudis A, Bland R, Newell ML, Glass RI, Parashar U, Jiang B. Differential profiles and inhibitory effect on rotavirus vaccines of nonantibody components in breast milk from mothers in developing and developed countries. The Pediatric Infectious Disease Journal. 32: 863-70. PMID 23584581 DOI: 10.1097/INF.0b013e318290646d |
0.345 |
|
| 2013 |
Payne DC, Boom JA, Staat MA, Edwards KM, Szilagyi PG, Klein EJ, Selvarangan R, Azimi PH, Harrison C, Moffatt M, Johnston SH, Sahni LC, Baker CJ, Rench MA, Donauer S, ... ... Tate JE, et al. Effectiveness of pentavalent and monovalent rotavirus vaccines in concurrent use among US children <5 years of age, 2009-2011. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 57: 13-20. PMID 23487388 DOI: 10.1093/cid/cit164 |
0.309 |
|
| 2013 |
Tate JE, Haynes A, Payne DC, Cortese MM, Lopman BA, Patel MM, Parashar UD. Trends in national rotavirus activity before and after introduction of rotavirus vaccine into the national immunization program in the United States, 2000 to 2012. The Pediatric Infectious Disease Journal. 32: 741-4. PMID 23426425 DOI: 10.1097/INF.0b013e31828d639c |
0.322 |
|
| 2013 |
Flannery B, Samad S, de Moraes JC, Tate JE, Danovaro-Holliday MC, de Oliveira LH, Rainey JJ. Uptake of oral rotavirus vaccine and timeliness of routine immunization in Brazil's National Immunization Program. Vaccine. 31: 1523-8. PMID 23313652 DOI: 10.1016/j.vaccine.2013.01.004 |
0.313 |
|
| 2013 |
Desai R, Cortese MM, Meltzer MI, Shankar M, Tate JE, Yen C, Patel MM, Parashar UD. Potential intussusception risk versus benefits of rotavirus vaccination in the United States. The Pediatric Infectious Disease Journal. 32: 1-7. PMID 22929172 DOI: 10.1097/Inf.0B013E318270362C |
0.354 |
|
| 2012 |
Patel MM, Clark AD, Sanderson CF, Tate J, Parashar UD. Removing the age restrictions for rotavirus vaccination: a benefit-risk modeling analysis. Plos Medicine. 9: e1001330. PMID 23109915 DOI: 10.1371/journal.pmed.1001330 |
0.322 |
|
| 2012 |
Boom JA, Sahni LC, Payne DC, Gautam R, Lyde F, Mijatovic-Rustempasic S, Bowen MD, Tate JE, Rench MA, Gentsch JR, Parashar UD, Baker CJ. Symptomatic infection and detection of vaccine and vaccine-reassortant rotavirus strains in 5 children: a case series. The Journal of Infectious Diseases. 206: 1275-9. PMID 22872730 DOI: 10.1093/infdis/jis490 |
0.34 |
|
| 2012 |
Kahn G, Fitzwater S, Tate J, Kang G, Ganguly N, Nair G, Steele D, Arora R, Chawla-Sarkar M, Parashar U, Santosham M. Epidemiology and prospects for prevention of rotavirus disease in India. Indian Pediatrics. 49: 467-74. PMID 22796685 DOI: 10.1007/S13312-012-0076-7 |
0.333 |
|
| 2012 |
Patel M, Pedreira C, De Oliveira LH, Umaña J, Tate J, Lopman B, Sanchez E, Reyes M, Mercado J, Gonzalez A, Perez MC, Balmaceda A, Andrus J, Parashar U. Duration of protection of pentavalent rotavirus vaccination in Nicaragua. Pediatrics. 130: e365-72. PMID 22753550 DOI: 10.1542/peds.2011-3478 |
0.355 |
|
| 2012 |
Lopman BA, Payne DC, Tate JE, Patel MM, Cortese MM, Parashar UD. Post-licensure experience with rotavirus vaccination in high and middle income countries; 2006 to 2011. Current Opinion in Virology. 2: 434-42. PMID 22749491 DOI: 10.1016/j.coviro.2012.05.002 |
0.374 |
|
| 2012 |
Patel MM, Glass R, Desai R, Tate JE, Parashar UD. Fulfilling the promise of rotavirus vaccines: how far have we come since licensure? The Lancet. Infectious Diseases. 12: 561-70. PMID 22742639 DOI: 10.1016/S1473-3099(12)70029-4 |
0.374 |
|
| 2012 |
Liu N, Yen C, Fang ZY, Tate JE, Jiang B, Parashar UD, Zeng G, Duan ZJ. Projected health impact and cost-effectiveness of rotavirus vaccination among children <5 years of age in China. Vaccine. 30: 6940-5. PMID 22705174 DOI: 10.1016/j.vaccine.2012.05.084 |
0.352 |
|
| 2012 |
Yen C, Tate JE, Steiner CA, Cortese MM, Patel MM, Parashar UD. Trends in intussusception hospitalizations among US infants before and after implementation of the rotavirus vaccination program, 2000-2009. The Journal of Infectious Diseases. 206: 41-8. PMID 22539812 DOI: 10.1093/infdis/jis314 |
0.305 |
|
| 2012 |
Atherly DE, Lewis KDC, Tate J, Parashar UD, Rheingans RD. Projected health and economic impact of rotavirus vaccination in GAVI-eligible countries: 2011-2030 Vaccine. 30: A7-A14. PMID 22520139 DOI: 10.1016/j.vaccine.2011.12.096 |
0.341 |
|
| 2012 |
Tate JE, Steele AD, Bines JE, Zuber PL, Parashar UD. Research priorities regarding rotavirus vaccine and intussusception: a meeting summary. Vaccine. 30: A179-84. PMID 22520129 DOI: 10.1016/j.vaccine.2011.08.110 |
0.341 |
|
| 2012 |
Desai R, Parashar UD, Lopman B, de Oliveira LH, Clark AD, Sanderson CF, Tate JE, Matus CR, Andrus JK, Patel MM. Potential intussusception risk versus health benefits from rotavirus vaccination in Latin America. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 54: 1397-405. PMID 22431803 DOI: 10.1093/cid/cis191 |
0.36 |
|
| 2012 |
Tate JE, Patel MM, Cortese MM, Lopman BA, Gentsch JR, Fleming J, Steele AD, Parashar UD. Remaining issues and challenges for rotavirus vaccine in preventing global childhood diarrheal morbidity and mortality. Expert Review of Vaccines. 11: 211-20. PMID 22309669 DOI: 10.1586/erv.11.184 |
0.37 |
|
| 2012 |
Tate JE, Burton AH, Boschi-Pinto C, Steele AD, Duque J, Parashar UD. 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis. The Lancet. Infectious Diseases. 12: 136-41. PMID 22030330 DOI: 10.1016/S1473-3099(11)70253-5 |
0.371 |
|
| 2011 |
Desai R, Oliveira LH, Parashar UD, Lopman B, Tate JE, Patel MM. Reduction in morbidity and mortality from childhood diarrhoeal disease after species A rotavirus vaccine introduction in Latin America - a review. MemóRias Do Instituto Oswaldo Cruz. 106: 907-11. PMID 22241109 |
0.379 |
|
| 2011 |
Yen C, Tate JE, Patel MM, Cortese MM, Lopman B, Fleming J, Lewis K, Jiang B, Gentsch J, Steele D, Parashar UD. Rotavirus vaccines: update on global impact and future priorities. Human Vaccines. 7: 1282-90. PMID 22108032 DOI: 10.4161/hv.7.12.18321 |
0.366 |
|
| 2011 |
Cortes JE, Curns AT, Tate JE, Cortese MM, Patel MM, Zhou F, Parashar UD. Rotavirus vaccine and health care utilization for diarrhea in U.S. children. The New England Journal of Medicine. 365: 1108-17. PMID 21992123 DOI: 10.1056/NEJMoa1000446 |
0.334 |
|
| 2011 |
Tate JE, Parashar UD. Monitoring impact and effectiveness of rotavirus vaccination. Expert Review of Vaccines. 10: 1123-5. PMID 21854307 DOI: 10.1586/erv.11.94 |
0.378 |
|
| 2011 |
Yen C, Figueroa JR, Uribe ES, Carmen-Hernández LD, Tate JE, Parashar UD, Patel MM, Richardson López-Collado V. Monovalent rotavirus vaccine provides protection against an emerging fully heterotypic G9P[4] rotavirus strain in Mexico. The Journal of Infectious Diseases. 204: 783-6. PMID 21810915 DOI: 10.1093/infdis/jir390 |
0.344 |
|
| 2011 |
Payne DC, Staat MA, Edwards KM, Szilagyi PG, Weinberg GA, Hall CB, Chappell J, Curns AT, Wikswo M, Tate JE, Lopman BA, Parashar UD. Direct and indirect effects of rotavirus vaccination upon childhood hospitalizations in 3 US Counties, 2006-2009. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 53: 245-53. PMID 21705316 DOI: 10.1093/cid/cir307 |
0.351 |
|
| 2011 |
Esposito DH, Holman RC, Haberling DL, Tate JE, Podewils LJ, Glass RI, Parashar U. Baseline estimates of diarrhea-associated mortality among United States children before rotavirus vaccine introduction. The Pediatric Infectious Disease Journal. 30: 942-7. PMID 21691244 DOI: 10.1097/INF.0b013e3182254d19 |
0.31 |
|
| 2011 |
Patel MM, López-Collada VR, Bulhões MM, De Oliveira LH, Bautista Márquez A, Flannery B, Esparza-Aguilar M, Montenegro Renoiner EI, Luna-Cruz ME, Sato HK, Hernández-Hernández Ldel C, Toledo-Cortina G, Cerón-RodrÃguez M, Osnaya-Romero N, MartÃnez-Alcazar M, ... ... Tate J, et al. Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil. The New England Journal of Medicine. 364: 2283-92. PMID 21675888 DOI: 10.1056/NEJMoa1012952 |
0.348 |
|
| 2011 |
Esposito DH, Tate JE, Kang G, Parashar UD. Projected impact and cost-effectiveness of a rotavirus vaccination program in India, 2008. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 52: 171-7. PMID 21288839 DOI: 10.1093/cid/ciq094 |
0.309 |
|
| 2011 |
Tate JE, Kisakye A, Mugyenyi P, Kizza D, Odiit A, Braka F. Projected health benefits and costs of pneumococcal and rotavirus vaccination in Uganda. Vaccine. 29: 3329-34. PMID 21241733 DOI: 10.1016/j.vaccine.2010.12.122 |
0.316 |
|
| 2011 |
Tate JE, Cortese MM, Payne DC, Curns AT, Yen C, Esposito DH, Cortes JE, Lopman BA, Patel MM, Gentsch JR, Parashar UD. Uptake, impact, and effectiveness of rotavirus vaccination in the United States: review of the first 3 years of postlicensure data. The Pediatric Infectious Disease Journal. 30: S56-60. PMID 21183842 DOI: 10.1097/INF.0b013e3181fefdc0 |
0.354 |
|
| 2011 |
Tate JE, Mutuc JD, Panozzo CA, Payne DC, Cortese MM, Cortes JE, Yen C, Esposito DH, Lopman BA, Patel MM, Parashar UD. Sustained decline in rotavirus detections in the United States following the introduction of rotavirus vaccine in 2006. The Pediatric Infectious Disease Journal. 30: S30-4. PMID 21183838 DOI: 10.1097/Inf.0B013E3181Ffe3Eb |
0.333 |
|
| 2011 |
Yen C, Tate JE, Wenk JD, Harris JM, Parashar UD. Diarrhea-associated hospitalizations among US children over 2 rotavirus seasons after vaccine introduction. Pediatrics. 127: e9-e15. PMID 21172995 DOI: 10.1542/peds.2010-1393 |
0.34 |
|
| 2011 |
Yen C, Armero Guardado JA, Alberto P, Rodriguez Araujo DS, Mena C, Cuellar E, Nolasco JB, De Oliveira LH, Pastor D, Tate JE, Parashar UD, Patel MM. Decline in rotavirus hospitalizations and health care visits for childhood diarrhea following rotavirus vaccination in El Salvador. The Pediatric Infectious Disease Journal. 30: S6-S10. PMID 21048524 DOI: 10.1097/INF.0b013e3181fefa05 |
0.353 |
|
| 2011 |
Jiang V, Jiang B, Tate J, Parashar UD, Patel MM. Performance of rotavirus vaccines in developed and developing countries. Human Vaccines. 6: 532-42. PMID 20622508 DOI: 10.4161/hv.6.7.11278 |
0.357 |
|
| 2010 |
Patel MM, Tate J, Cortese M, Payne DC, Armstrong G, Parashar UD, Lopman B. The impact of indirect benefits of vaccination on postlicensure vaccine effectiveness estimates: A scenario analysis Vaccine. 28: 7987-7992. PMID 20875493 DOI: 10.1016/j.vaccine.2010.09.044 |
0.342 |
|
| 2010 |
Boom JA, Tate JE, Sahni LC, Rench MA, Quaye O, Mijatovic-Rustempasic S, Patel MM, Baker CJ, Parashar UD. Sustained protection from pentavalent rotavirus vaccination during the second year of life at a large, urban United States pediatric hospital. The Pediatric Infectious Disease Journal. 29: 1133-5. PMID 20634776 DOI: 10.1097/Inf.0B013E3181Ed18Ab |
0.347 |
|
| 2010 |
de Palma O, Cruz L, Ramos H, de Baires A, Villatoro N, Pastor D, de Oliveira LH, Kerin T, Bowen M, Gentsch J, Esposito DH, Parashar U, Tate J, Patel M. Effectiveness of rotavirus vaccination against childhood diarrhoea in El Salvador: case-control study. Bmj (Clinical Research Ed.). 340: c2825. PMID 20551120 DOI: 10.1136/bmj.c2825 |
0.354 |
|
| 2010 |
Patel M, Rench MA, Boom JA, Tate JE, Sahni LC, Hull JA, Gentsch JR, Parashar UD, Baker CJ. Detection of rotavirus antigenemia in routinely obtained serum specimens to augment surveillance and vaccine effectiveness evaluations. The Pediatric Infectious Disease Journal. 29: 836-9. PMID 20526226 DOI: 10.1097/INF.0b013e3181e753d1 |
0.312 |
|
| 2010 |
Tate JE, Patel MM, Steele AD, Gentsch JR, Payne DC, Cortese MM, Nakagomi O, Cunliffe NA, Jiang B, Neuzil KM, de Oliveira LH, Glass RI, Parashar UD. Global impact of rotavirus vaccines. Expert Review of Vaccines. 9: 395-407. PMID 20370550 DOI: 10.1586/erv.10.17 |
0.369 |
|
| 2010 |
Cortese MM, Tate JE, Simonsen L, Edelman L, Parashar UD. Reduction in gastroenteritis in United States children and correlation with early rotavirus vaccine uptake from national medical claims databases. The Pediatric Infectious Disease Journal. 29: 489-94. PMID 20354464 DOI: 10.1097/INF.0b013e3181d95b53 |
0.339 |
|
| 2010 |
Boom JA, Tate JE, Sahni LC, Rench MA, Hull JJ, Gentsch JR, Patel MM, Baker CJ, Parashar UD. Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States. Pediatrics. 125: e199-207. PMID 20083525 DOI: 10.1542/peds.2009-1021 |
0.302 |
|
| 2010 |
Amador JJ, Vasquez J, Orozco M, Pedreira C, Malespin O, De Oliveira LH, Tate J, Parashar U, Patel M. Rotavirus disease burden, Nicaragua 2001-2005: defining the potential impact of a rotavirus vaccination program. International Journal of Infectious Diseases : Ijid : Official Publication of the International Society For Infectious Diseases. 14: e592-5. PMID 20022778 DOI: 10.1016/j.ijid.2009.08.014 |
0.351 |
|
| 2010 |
Cortes J, Esposito D, Cortese M, Bartlett D, Tate J, Payne D, Patel M, Curns A, Gentsch J, Parashar U. Uptake and impact of Rotavirus vaccines in US Children International Journal of Infectious Diseases. 14: e175-e176. DOI: 10.1016/J.IJID.2010.02.1875 |
0.321 |
|
| 2009 |
Orozco M, Vasquez J, Pedreira C, De Oliveira LH, Amador JJ, Malespin O, Andrus J, Tate J, Parashar U, Patel M. Uptake of rotavirus vaccine and national trends of acute gastroenteritis among children in Nicaragua. The Journal of Infectious Diseases. 200: S125-30. PMID 19821709 DOI: 10.1086/605053 |
0.356 |
|
| 2009 |
Tate JE, Rheingans RD, O'Reilly CE, Obonyo B, Burton DC, Tornheim JA, Adazu K, Jaron P, Ochieng B, Kerin T, Calhoun L, Hamel M, Laserson K, Breiman RF, Feikin DR, et al. Rotavirus disease burden and impact and cost-effectiveness of a rotavirus vaccination program in kenya. The Journal of Infectious Diseases. 200: S76-84. PMID 19817618 DOI: 10.1086/605058 |
0.322 |
|
| 2009 |
Tate JE, Panozzo CA, Payne DC, Patel MM, Cortese MM, Fowlkes AL, Parashar UD. Decline and change in seasonality of US rotavirus activity after the introduction of rotavirus vaccine. Pediatrics. 124: 465-71. PMID 19581260 DOI: 10.1542/Peds.2008-3528 |
0.315 |
|
| 2009 |
Patel M, Pedreira C, De Oliveira LH, Tate J, Orozco M, Mercado J, Gonzalez A, Malespin O, Amador JJ, Umaña J, Balmaseda A, Perez MC, Gentsch J, Kerin T, Hull J, et al. Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua. Jama. 301: 2243-51. PMID 19491186 DOI: 10.1001/jama.2009.756 |
0.366 |
|
| 2009 |
Patel MM, Clark AD, Glass RI, Greenberg H, Tate J, Santosham M, Sanderson CF, Steele D, Cortese M, Parashar UD. Broadening the age restriction for initiating rotavirus vaccination in regions with high rotavirus mortality: benefits of mortality reduction versus risk of fatal intussusception. Vaccine. 27: 2916-22. PMID 19428901 DOI: 10.1016/J.Vaccine.2009.03.016 |
0.377 |
|
| 2009 |
Tate JE, Curns AT, Cortese MM, Weintraub ES, Hambidge S, Zangwill KM, Patel MM, Baggs JM, Parashar UD. Burden of acute gastroenteritis hospitalizations and emergency department visits in US children that is potentially preventable by rotavirus vaccination: a probe study using the now-withdrawn rotashield vaccine. Pediatrics. 123: 744-9. PMID 19254997 DOI: 10.1542/peds.2008-1200 |
0.361 |
|
| 2008 |
Tate JE, Simonsen L, Viboud C, Steiner C, Patel MM, Curns AT, Parashar UD. Trends in intussusception hospitalizations among US infants, 1993-2004: implications for monitoring the safety of the new rotavirus vaccination program. Pediatrics. 121: e1125-32. PMID 18450856 DOI: 10.1542/peds.2007-1590 |
0.323 |
|
| Show low-probability matches. |